Content about Bupropion

November 27, 2012
Wockhardt receives three FDA approvals

Indian generic drug maker Wockhardt received three new drug approvals from the Food and Drug Administration, agency records show.

November 1, 2012
Reports: Generic extended-release drugs to get more attention from FDA

Some generic drugs may come under more scrutiny from the Food and Drug Administration amid reports that the generic version of a treatment for depression didn't work as well as the branded version, according to published reports.

October 22, 2012
Watson, Actavis divest more drugs as condition for FTC merger approval

Watson Pharmaceuticals and Actavis will have to divest rights to almost two dozen drugs as a condition for U.S. regulatory approval of their $5.6 billion merger announced earlier this year, according to regulatory documents.

October 19, 2012
JAMA: Director of tobacco research suggests most benefits outweigh risks when considering cessation

Smokers who have been unsuccessful to date in trying to kick the nicotine habit may be able to stop smoking by combining two smoking cessation approaches, according to a report published in the Oct. 17 issue of JAMA.

October 5, 2012
FDA issues new guidelines for budeprion XL in the 300-mg strength

The Food and Drug Administration has reviewed new data that indicated that budeprion XL (bupropion hydrochloride extended-release tablets) in the 300-mg strength, manufactured by Impax Labs and Teva Pharmaceuticals USA, is not therapeutically equivalent to Wellbutrin XL in the 300-mg strength.

September 4, 2012
FDA approves Wockhardt antidepressant

The Food and Drug Administration has approved a generic antidepressant made by Wockhardt, the Indian drug maker said Tuesday.

September 22, 2011
Orexigen, FDA work out plan for path to approval of obesity drug

Drug maker Orexigen Therapeutics said it had identified a "clear and feasible path" for the approval of its drug for treating obesity by working with the Food and Drug Administration.

February 1, 2011
FDA declines to approve Contrave

The Food and Drug Administration has turned down an application for an anti-obesity drug.

December 8, 2010
FDA panel backs Contrave

A Food and Drug Administration advisory committee has recommended approval for an investigational diet pill.

December 7, 2010
Nonprofits urge for more means of addressing obesity epidemic

As a Food and Drug Administration advisory committee convenes to decide whether or not to approve a new drug for treating obesity, two nonprofit groups centered on the epidemic said more means of addressing it are needed.

November 14, 2010
Out-of-pocket costs vary widely for branded, generic drugs

The often wide gap between what consumers will pay out of pocket for a branded...

September 30, 2010
Mylan's generic Wellbutrin XL enters market

Mylan has launched a generic version of a common antidepressant, the company said Friday....

July 20, 2010
Caraco launches generic Wellbutrin SR

Generic drug maker Caraco Pharmaceutical Labs has launched a generic antidepressant, Caraco said Wednesday....

July 20, 2010
FDA approves additional strengths of Actavis' generic Wellbutrin SR

Actavis has received regulatory approval from the Food and Drug Administration for a generic antidepressant,...

June 20, 2010
Valeant, Biovail to merge

U.S. drug maker Valeant and Canadian drug maker Biovail will merge, the two companies said...

May 3, 2010
Mylan gets regulatory approval for generic Zyban

The Food and Drug Administration has approved Mylan’s generic version of a smoking-cessation drug, Mylan...

February 20, 2010
Watson seeks FDA approval for depression generic

Watson Pharmaceuticals has filed a regulatory approval application with the Food and Drug Administration for...

© 2013 Drug Store News. All Rights Reserved.